Literature DB >> 23512739

Research progress on the NLRP3 inflammasome and its role in the central nervous system.

Shen-Bin Liu1, Wen-Li Mi, Yan-Qing Wang.   

Abstract

The NLRP3 inflammasome, which consists of the NLRP3 (nucleotide-binding oligomerization domain (Nod)-like receptor 3) scaffold, the ASC (apoptosis-associated speck-like protein containing a CARD) adaptor and procaspase- 1, is assembled after the cytoplasmic LRRs (leucine-rich repeats) of NLRP3 sense pathogens or danger signals. The NLRP3 inflammasome controls the activation of the proteolytic enzyme caspase-1. Caspase-1 in turn regulates the maturation of the proinflammasome cytokines IL-1β and IL-18, which leads to an inflammatory response. The inflammasome plays an important role in the development of Alzheimer's disease and bacterial meningitis, and the NLRP3 inflammasome may become a new target for the prevention and treatment of central nervous system diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23512739      PMCID: PMC5561828          DOI: 10.1007/s12264-013-1328-9

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  81 in total

1.  The NLRP3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsin B release.

Authors:  Tobias Hoegen; Nadin Tremel; Matthias Klein; Barbara Angele; Hermann Wagner; Carsten Kirschning; Hans-Walter Pfister; Adriano Fontana; Sven Hammerschmidt; Uwe Koedel
Journal:  J Immunol       Date:  2011-10-14       Impact factor: 5.422

2.  A role for mitochondria in NLRP3 inflammasome activation.

Authors:  Rongbin Zhou; Amir S Yazdi; Philippe Menu; Jürg Tschopp
Journal:  Nature       Date:  2010-12-01       Impact factor: 49.962

3.  Th1 and Th17 cells regulate innate immune responses and bacterial clearance during central nervous system infection.

Authors:  Monica M Holley; Tammy Kielian
Journal:  J Immunol       Date:  2011-12-21       Impact factor: 5.422

4.  HIV-1 induces NALP3-inflammasome expression and interleukin-1β secretion in dendritic cells from healthy individuals but not from HIV-positive patients.

Authors:  Alessandra Pontillo; Lais T Silva; Telma M Oshiro; Claudia Finazzo; Sergio Crovella; Alberto J S Duarte
Journal:  AIDS       Date:  2012-01-02       Impact factor: 4.177

5.  Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies.

Authors:  Hal M Hoffman; Martin L Throne; N J Amar; Mohamed Sebai; Alan J Kivitz; Arthur Kavanaugh; Steven P Weinstein; Pavel Belomestnov; George D Yancopoulos; Neil Stahl; Scott J Mellis
Journal:  Arthritis Rheum       Date:  2008-08

6.  MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniae in the CNS.

Authors:  Uwe Koedel; Tobias Rupprecht; Barbara Angele; Juergen Heesemann; Hermann Wagner; Hans-Walter Pfister; Carsten J Kirschning
Journal:  Brain       Date:  2004-04-28       Impact factor: 13.501

7.  Use of canakinumab in the cryopyrin-associated periodic syndrome.

Authors:  Helen J Lachmann; Isabelle Kone-Paut; Jasmin B Kuemmerle-Deschner; Kieron S Leslie; Eric Hachulla; Pierre Quartier; Xavier Gitton; Albert Widmer; Neha Patel; Philip N Hawkins
Journal:  N Engl J Med       Date:  2009-06-04       Impact factor: 91.245

8.  Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels.

Authors:  Déborah Tribouillard-Tanvier; James F Striebel; Karin E Peterson; Bruce Chesebro
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

9.  Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth.

Authors:  Mélanie Bruchard; Grégoire Mignot; Valentin Derangère; Fanny Chalmin; Angélique Chevriaux; Frédérique Végran; Wilfrid Boireau; Benoit Simon; Bernhard Ryffel; Jean Louis Connat; Jean Kanellopoulos; François Martin; Cédric Rébé; Lionel Apetoh; François Ghiringhelli
Journal:  Nat Med       Date:  2012-12-02       Impact factor: 53.440

10.  Pannexin-1-mediated intracellular delivery of muramyl dipeptide induces caspase-1 activation via cryopyrin/NLRP3 independently of Nod2.

Authors:  Noemí Marina-García; Luigi Franchi; Yun-Gi Kim; Douglas Miller; Christine McDonald; Geert-Jan Boons; Gabriel Núñez
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

View more
  15 in total

Review 1.  The role of the inflammasome in cardiovascular diseases.

Authors:  Xuan Li; Nicolas Deroide; Ziad Mallat
Journal:  J Mol Med (Berl)       Date:  2014-03-19       Impact factor: 4.599

Review 2.  NLRP3 inflammasome: a promising target in ischemic stroke.

Authors:  Li Gao; Qing Dong; Zhenghong Song; Fei Shen; Jianquan Shi; Yansheng Li
Journal:  Inflamm Res       Date:  2016-08-30       Impact factor: 4.575

3.  Low-variance RNAs identify Parkinson's disease molecular signature in blood.

Authors:  Maria D Chikina; Christophe P Gerald; Xianting Li; Yongchao Ge; Hanna Pincas; Venugopalan D Nair; Aaron K Wong; Arjun Krishnan; Olga G Troyanskaya; Deborah Raymond; Rachel Saunders-Pullman; Susan B Bressman; Zhenyu Yue; Stuart C Sealfon
Journal:  Mov Disord       Date:  2015-03-18       Impact factor: 10.338

4.  Anti-inflammatory interventions-what has worked, not worked, and what may work in the future.

Authors:  Fatemeh Fattahi; Peter A Ward
Journal:  Transl Res       Date:  2015-08-14       Impact factor: 7.012

5.  Dopamine D1 receptor agonist A-68930 inhibits NLRP3 inflammasome activation and protects rats from spinal cord injury-induced acute lung injury.

Authors:  W Jiang; M Li; F He; Z Bian; J Liu; Q He; X Wang; T Sun; L Zhu
Journal:  Spinal Cord       Date:  2016-04-12       Impact factor: 2.772

6.  NLRP3 inflammasome signaling as an early molecular response is negatively controlled by miR-186 in CFA-induced prosopalgia mice.

Authors:  Ming-Lei Chen; Kang Lin; Shu-Kai Lin
Journal:  Braz J Med Biol Res       Date:  2018-07-16       Impact factor: 2.590

7.  Inhibition of NLRP3 Inflammasome Ameliorates Cerebral Ischemia-Reperfusion Injury in Diabetic Mice.

Authors:  Pu Hong; Feng-Xian Li; Ruo-Nan Gu; Ying-Ying Fang; Lu-Ying Lai; Yong-Wei Wang; Tao Tao; Shi-Yuan Xu; Zhi-Jian You; Hong-Fei Zhang
Journal:  Neural Plast       Date:  2018-04-24       Impact factor: 3.599

8.  Development of a Gill Assay Library for Ecological Proteomics of Threespine Sticklebacks (Gasterosteus aculeatus).

Authors:  Johnathon Li; Bryn Levitan; Silvia Gomez-Jimenez; Dietmar Kültz
Journal:  Mol Cell Proteomics       Date:  2018-08-09       Impact factor: 5.911

9.  Activation of the NLRP3 inflammasome in lipopolysaccharide-induced mouse fatigue and its relevance to chronic fatigue syndrome.

Authors:  Zi-Teng Zhang; Xiu-Ming Du; Xiu-Juan Ma; Ying Zong; Ji-Kuai Chen; Chen-Lin Yu; Yan-Gang Liu; Yong-Chun Chen; Li-Jun Zhao; Guo-Cai Lu
Journal:  J Neuroinflammation       Date:  2016-04-05       Impact factor: 8.322

10.  Curcumin ameliorates neuropathic pain by down-regulating spinal IL-1β via suppressing astroglial NALP1 inflammasome and JAK2-STAT3 signalling.

Authors:  Shenbin Liu; Qian Li; Meng-Ting Zhang; Qi-Liang Mao-Ying; Lang-Yue Hu; Gen-Cheng Wu; Wen-Li Mi; Yan-Qing Wang
Journal:  Sci Rep       Date:  2016-07-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.